Using the latest TTM figures, Abbott Laboratories shows a gross margin of 56.6%, an operating margin of 15.8%, an EBITDA margin of 25.2%, and a net margin of 11.6%. Margin expansion was strongest in gross margin, which increased by 0.6 percentage points. Net margin had the strongest contraction, declining by 20.8 percentage points.
Over the last 3 years, Abbott Laboratories recorded average margins of 55.7% gross, 16.53% operating, 26.05% EBITDA, and 19.76% net. Abbott Laboratories's current performance shows that gross margin is above its three-year average and operating, EBITDA, and net margins are below their three-year averages.
Gross margin expanded by 0.6 percentage points, but operating margin contracted by 1.6 percentage points, EBITDA margin by 1.6 percentage points, and net margin by 20.8 percentage points.
Looking at the last 3 years, Abbott Laboratories had an average gross margin of 55.7%. As of the latest period, Abbott Laboratories's current gross margin is 56.6%, which is 0.9 percentage points above its three-year average. Looking back over the last 3 years, Abbott Laboratories's gross margin reached 56.6% at its highest point in Jun 2026 and 54.9% at its lowest in Sep 2023.
Over the last 3 years, the average operating margin for Abbott Laboratories was 16.53%. At present, the current operating margin for Abbott Laboratories is 15.8%, 0.7 percentage points below its three-year average. Abbott Laboratories's operating margin ranged from a low of 15% in Sep 2023 to a high of 18.2% in Dec 2025.
Across the last 3 years, Abbott Laboratories recorded an average EBITDA margin of 26.05%. Abbott Laboratories currently reports an EBITDA margin of 25.2%, 0.9 percentage points below its three-year average. The highest EBITDA margin for Abbott Laboratories was 27.2% in Dec 2025, while the lowest was 25.2% in Sep 2023.
In the last 3 years, Abbott Laboratories had an average net margin of 19.76%. Against its three-year average, Abbott Laboratories's net margin is currently 11.6%, 8.2 percentage points below its three-year average. Looking back over the last 3 years, Abbott Laboratories's net margin reached 32.4% at its highest point in Jun 2025 and 11.6% at its lowest in Jun 2026.
Abbott Laboratories's gross margin of 56.6% is below the Healthcare sector, the industry and its peers average. Looking at its Healthcare sector average of 68.5%, Abbott Laboratories's gross margin is 17% lower.
As of Jun 30, 2026, ABT has a gross margin of 56.6%.
For the period ending Jun 30, 2026, ABT recorded an operating margin of 15.8%.
For the period ending Jun 30, 2026, ABT recorded an EBITDA margin of 25.2%.
As of Jun 30, 2026, ABT has a net margin of 11.6%.
Abbott Laboratories's gross, operating, EBITDA, and net margins averaged 55.7% gross, 16.5% operating, 26.1% EBITDA, and 19.8% net over the last 3 years.
Over this 5-year history, ABT peaked at 58% gross in Jun 2022, 22.4% operating in Jun 2022, 30.6% EBITDA in Jun 2022, and 32.4% net in Jun 2025.
In the last 5 years, the lowest margins reported by ABT were 54.9% gross in Sep 2023, 15% operating in Sep 2023, 25.1% EBITDA in Jun 2023, and 11.6% net in Jun 2026.